Street Capital Inc.

OTC: REZNF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONReports USD

#1143 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

17D

FH 15DQ —GM 18SS 30

v0.1 · 45/100 weight · provisional

↑ workforce scale, growth stability · ↓ revenue growth (YoY), 3-yr revenue growth

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$111.5k

Employees

Market cap

$56.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$111.5k-155.8k CAD2025

Operating income-$120.5k-168.4k CAD2025

Total assets$57.4k78.6k CAD2025

Liabilities$284.8k390.3k CAD2025

Equity-$227.4k-311.7k CAD2025

Revenue trend

FY2017 – FY2025 · USD

FY17

FY18

FY19

FY20

$659.8k

FY21

$619.2k

FY22

$410.4k

FY23

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Street Capital Inc. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

T2 Biosystems, Inc.——Tristar Wellness Solutions Inc.——Biome Grow Inc.——Mera Pharmaceuticals, Inc.——

Key facts

CEOChris Savoie

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: REZNF

Employees72

IPO date2021-09-24

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.